XML 61 R44.htm IDEA: XBRL DOCUMENT
v3.25.3

EQUITY METHOD INVESTMENT AND NOTE RECEIVABLE (Tables) | 12 Months Ended
--- | ---
Sep. 30, 2025
Equity Method Investments and Joint Ventures [Abstract] |
Schedule of Financial Information | Summarized financial information for Copeland for 2024 and 2023 is presented below. Copeland's results only reflect activity subsequent to the Company's divestiture of its majority stake and through the completion of the sale of the 40 percent non-controlling common equity interest.
| 2023 |  |  | 2024 |
Net sales | $ | 1,677 |  |  | $ | 4,323 |
Gross profit | $ | 479 |  |  | $ | 1,495 |
Income (loss) from continuing operations | $ | (442) |  |  | $ | (326) |
Net income (loss) | $ | (442) |  |  | $ | (326) |
Net income (loss) attributable to shareholders | $ | (442) |  |  | $ | (322) |

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration